The gastric H,K ATPase as a drug target: past, present, and future - Wikidata - wikimedia - TriplyDB

The gastric H,K ATPase as a drug target: past, present, and future

The gastric H,K ATPase as a drug target: past, present, and future

http://www.wikidata.org/entity/Q24631084

about

Pharmacological interventions for prevention and treatment of upper gastrointestinal bleeding in newborn infants The gastric HK-ATPase: structure, function, and inhibition Acid-base transport in pancreas-new challenges Active detergent-solubilized H+,K+-ATPase is a monomer Long lasting inhibitors of the gastric H,K-ATPase The renal H+-K+-ATPases: physiology, regulation, and structure H+/K+-ATPase inhibitors: a patent review.Antacids and dietary supplements with an influence on the gastric pH increase the risk for food sensitization Review article: dual delayed release formulation of dexlansoprazole MR, a novel approach to overcome the limitations of conventional single release proton pump inhibitor therapy.Protonated form: the potent form of potassium-competitive acid blockers Proton Pump Inhibitors Inhibit Pancreatic Secretion: Role of Gastric and Non-Gastric H+/K+-ATPases.The Significance of Variceal Haemorrhage in Ghana: A Retrospective Review.Effects of rabeprazole on bone metabolic disorders in a gastrectomized rat model Secretagogue stimulation enhances NBCe1 (electrogenic Na(+)/HCO(3)(-) cotransporter) surface expression in murine colonic crypts Pharmacokinetic- pharmacodynamic analysis of the role of CYP2C19 genotypes in short-term rabeprazole-based triple therapy against Helicobacter pylori Recent advances in the molecular and functional characterization of acid/base and electrolyte transporters in the basolateral membranes of gastric and duodenal epithelial cells.Acid peptic diseases: pharmacological approach to treatment.Proton pump inhibitors in pediatrics : mechanism of action, pharmacokinetics, pharmacogenetics, and pharmacodynamics.Randomised clinical trial: safety, tolerability, pharmacokinetics and pharmacodynamics of repeated doses of TAK-438 (vonoprazan), a novel potassium-competitive acid blocker, in healthy male subjects.Privileged Electrophile Sensors: A Resource for Covalent Drug Development.Dexlansoprazole: delayed-release orally disintegrating tablets for the treatment of heartburn associated with non-erosive gastroesophageal reflux disease and the maintenance of erosive esophagitis.Multifunctional molecule ERp57: From cancer to neurodegenerative diseases.Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Single Rising TAK-438 (Vonoprazan) Doses in Healthy Male Japanese/non-Japanese Subjects.Computational insights into the interaction mechanism of triazolyl substituted tetrahydrobenzofuran derivatives with H(+),K(+)-ATPase at different pH.Pancreatic bicarbonate secretion involves two proton pumps.Functional coupling of chloride-proton exchanger ClC-5 to gastric H+,K+-ATPase E2P state stabilization by the N-terminal tail of the H,K-ATPase beta-subunit is critical for efficient proton pumping under in vivo conditions.Impact of Gastric H+/K+-ATPase rs2733743 on the Intragastric pH-Values of Dexlansoprazole Injection in Chinese Subjects.Functional association between K+-Cl- cotransporter-4 and H+,K+-ATPase in the apical canalicular membrane of gastric parietal cells.Molecular mechanism and functional consequences of lansoprazole-mediated heme oxygenase-1 induction.Rabeprazole can overcome the impact of CYP2C19 polymorphism on quadruple therapy.A comparison of the acid-inhibitory effects of esomeprazole and pantoprazole in relation to pharmacokinetics and CYP2C19 polymorphism.Omeprazole enhances the colonic expression of the Mg(2+) transporter TRPM6.Functional significance of E2 state stabilization by specific alpha/beta-subunit interactions of Na,K- and H,K-ATPase.Fluorescent Visualization of Cellular Proton Fluxes.Gastric Volume and Its Relationship to Underlying Pathology or Acid-suppressing Medication.In vitro metabolism of TAK-438, vonoprazan fumarate, a novel potassium-competitive acid blocker.2-(1H-Benzimidazol-2-yl)-4,5,6,7-tetrahydro-2H-indazol-3-ol, a benzimidazole derivative, inhibits T cell proliferation involving H+/K+-ATPase inhibition.Negative Effect of Proton-pump Inhibitors (PPIs) on Helicobacter pylori Growth, Morphology, and Urease Test and Recovery after PPI Removal--An In vitro Study.Ion Motive ATPases: P-type ATPases

P2860

Q24186815-D5C50F95-1193-4888-91AC-812A551D1B81 Q24612375-9E93AD69-F151-43C9-B2B3-66E91DA6815B Q26998861-97635FDF-616D-41F7-B071-1A88D122E21B Q28276805-E15C11B3-B986-4072-83AC-58B90290DD74 Q28299927-E172788A-8D0C-43F2-B976-1D9CA404C7C2 Q33589092-E2CB3792-6D66-4FAA-B6C5-6F60C176549C Q34315036-60BA687D-E5A2-43EB-8180-8E3CACC787BF Q34394258-2835D5BC-CA1A-41A0-881F-EC7376FC4C20 Q34965332-1104EE25-5A12-4307-A300-55F67041E950 Q35171617-A1A54071-F20B-4E81-901F-6EEBBF3396E6 Q35636415-79659BB6-E495-44A1-8A50-29FBCCFFE52D Q36365415-D4D6EB94-0010-4D7B-885E-DCC5CC82DC4F Q37001665-5861EA6B-8A4F-4C9F-BEDC-BCDA2D86DC0E Q37174848-FE8BBC78-F404-4C46-8B08-DB9FA44C138B Q37201668-B0219BCB-3309-4ACF-9C8C-ABB7ADE4062F Q37717739-C7EC5198-AC68-4E4B-B6F9-B0E9871E015E Q37913063-F00D256B-B005-4E80-B1FC-40913CF2E311 Q38091317-AF0E5079-AB42-40F8-8B79-A9687FB0B235 Q38415822-B670A4F6-2542-4C10-B6C8-322B55936BAB Q38710055-98C468CA-417A-421F-BC08-B39E55A83C75 Q38825937-C1D79C32-0A03-4215-86C5-7707C2FE76E5 Q39445097-D864F698-D012-42CC-952A-6E7966241B91 Q39746768-762BC05F-68B0-457C-BEC4-A45166BBA354 Q40212184-A88414AD-B1F3-4616-9A7A-C0EE1886753B Q41556981-366DEA7D-21DB-4B7D-B228-A54FD96ABF0F Q41872254-09CDE83E-3762-42E6-B53A-60CF0ABB3267 Q42056103-19DA2487-4972-4C4B-87AD-FA4609F7AF8F Q42364580-A7158944-83DE-4836-8BB4-141F9D8F6A2F Q42444367-BCA0175A-8C61-4F66-BE04-437F93319EAE Q42560063-E2DDEC50-5416-438C-97DB-C4D1B504F737 Q42969515-7DCA1798-B03B-4D7D-A147-3BE3D76E9E92 Q43270261-0A207798-67F4-4C1A-9928-9A8BBC8ED72B Q43457054-36D34E63-2918-4930-8CF2-78C8D7CBD057 Q46209261-6C45531C-38B2-4526-8602-A37F07B744EF Q46766536-089B193B-B64C-448C-8FBB-4A69145F9A16 Q47163832-A73FF835-6437-41A5-91CB-028AAA2FA822 Q51642470-6B7CE27D-456C-4ECE-B85A-AD6F3D28432D Q53008503-FE3FFC26-8149-491D-AA82-B34FA340E768 Q53402835-B159F85D-A5D6-43B1-94F9-985C2618B742 Q57320170-879019B0-F771-4524-B7C6-FADE34D626FC

P2860

The gastric H,K ATPase as a drug target: past, present, and future

http://www.wikidata.org/entity/Q24631084

description

2007 nî lūn-bûn

@nan

2007 թուականի Յուլիսին հրատարակուած գիտական յօդուած

@hyw

2007 թվականի հուլիսին հրատարակված գիտական հոդված

@hy

2007年の論文

@ja

2007年論文

@yue

2007年論文

@zh-hant

2007年論文

@zh-hk

2007年論文

@zh-mo

2007年論文

@zh-tw

2007年论文

@wuu

name

The gastric H,K ATPase as a drug target: past, present, and future

@ast

The gastric H,K ATPase as a drug target: past, present, and future

@en

The gastric H,K ATPase as a drug target: past, present, and future

@nl

type

label

The gastric H,K ATPase as a drug target: past, present, and future

@ast

The gastric H,K ATPase as a drug target: past, present, and future

@en

The gastric H,K ATPase as a drug target: past, present, and future

@nl

prefLabel

The gastric H,K ATPase as a drug target: past, present, and future

@ast

The gastric H,K ATPase as a drug target: past, present, and future

@en

The gastric H,K ATPase as a drug target: past, present, and future

@nl

P1433

Q24631084-A62AB52C-F892-4C57-B0A6-0903B5A4AE7E

P1476

Q24631084-30579B88-4F54-41F7-8014-B8900D5C923F

P2093

Q24631084-4BE1018B-21F5-4E85-BF49-BBC8A517EB0E

Q24631084-8630E531-46E7-45FB-9D93-DCF3AC487149

Q24631084-8F4F0DAB-4594-4D2F-9FFB-979D5BD37059

Q24631084-98859561-BBE0-41D7-89F0-94D1B9ECE78F

P2860

Q24631084-01145DA6-9AE1-4671-B1EC-B83ABB5179C6

Q24631084-0723A188-4416-4A5C-95C1-69DB6787C826

Q24631084-0AD28835-4BED-41A8-82A5-E3EF7BC9321A

Q24631084-0B9E7447-5A8C-4F47-A1D7-9A8D640406D1

Q24631084-0E4C289B-2BD7-4A27-812F-780AE3096D73

Q24631084-2ABF3617-A251-4D4C-B1EC-2AC40BED5655

Q24631084-3801535A-8D31-40AB-93F5-6D3248B31FD3

Q24631084-4408389D-F102-4DD3-8F75-F94A10AB8573

Q24631084-5C0325C3-670C-46A1-AF9B-F14575DFA4F5

Q24631084-6D0BFE84-0F32-4BD5-91F1-7A78EAF97156

P304

Q24631084-41DFC1BD-8DF3-4476-9A43-57E5A887F062

P31

Q24631084-25E31A83-766D-436C-940A-4CC758C6AFBC

P356

Q24631084-4EE85BBD-887C-45A8-B0CB-6A33B2071C59

P407

Q24631084-9DF8D5D8-55B0-4AFE-9179-484A0C3D6DF5

P433

Q24631084-056B0379-2ED1-4096-BCDA-4EE1D1C93786

P478

Q24631084-010A989D-3DB9-4BFD-9877-E6D306B37A0B

P50

Q24631084-ADB4DFAE-B460-425F-BAD3-ABD40AC6B579

Q24631084-B552DCA3-7233-4629-A90D-DF0718D53B04

P577

Q24631084-FDD7995F-4C71-4B0E-AF5B-E328A2A6FAFB

P5875

Q24631084-CB4B0CC0-EF1F-4475-B90C-A8BFED105716

P698

Q24631084-8E52425E-DECC-4B36-A607-A12535824935

P932

Q24631084-7678C76D-7FB7-40A6-8C3F-8EFF6E216134

P356

MCG.0B013E31803233B7

P1433

Journal of Clinical Gastroenterology

P1476

The gastric H,K ATPase as a drug target: past, present, and future

@en

P2093

George Sachs

http://www.w3.org/2001/XMLSchema#string

Jai Moo Shin

http://www.w3.org/2001/XMLSchema#string

Keith Munson

http://www.w3.org/2001/XMLSchema#string

Olga Vagin

http://www.w3.org/2001/XMLSchema#string

P2860

SNAP family of NSF attachment proteins includes a brain-specific isoform

Inwardly rectifying K+ channel Kir7.1 is highly expressed in thyroid follicular cells, intestinal epithelial cells and choroid plexus epithelial cells: implication for a functional coupling with Na+,K+-ATPase

Modeling of the inhibitory interaction of phospholamban with the Ca2+ ATPase.

Specific localization of an inwardly rectifying K(+) channel, Kir4.1, at the apical membrane of rat gastric parietal cells; its possible involvement in K(+) recycling for the H(+)-K(+)-pump

Crystal structure of the calcium pump of sarcoplasmic reticulum at 2.6 A resolution

Structural changes in the calcium pump accompanying the dissociation of calcium

The KCNE2 potassium channel ancillary subunit is essential for gastric acid secretion

Transcriptomes of purified gastric ECL and parietal cells: identification of a novel pathway regulating acid secretion

The cardiac K+ channel KCNQ1 is essential for gastric acid secretion

KCNQ1-dependent transport in renal and gastrointestinal epithelia

P304

S226-42

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1097/MCG.0B013E31803233B7

http://www.w3.org/2001/XMLSchema#string

P407

P433

Supplement 2

http://www.w3.org/2001/XMLSchema#string

P478

41 Suppl 2

http://www.w3.org/2001/XMLSchema#string

P50

Iskandar Yakubov

P577

2007-07-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

6260668

http://www.w3.org/2001/XMLSchema#string

P698

17575528

http://www.w3.org/2001/XMLSchema#string

P932

2860960

http://www.w3.org/2001/XMLSchema#string